← All Sponsors
SPONSOR

Shenzhen Resproly Biopharmaceutical Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
NCT06482190 Phase 1
Recruiting

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Idiopathic Pulmonary Fibrosis
Australia View Trial →